Tel:
Fax:
Email:
Creative Biolabs

NeuroMab™ Anti-FGFR3 BBB Shuttle Antibody(NRZP-1022-ZP3905)

[CAT#: NRZP-1022-ZP3905]

Host Species:
Mouse
Species Reactivity:
Human
Applications:
Block; Inhib; In Vitro; In Vivo

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry

SPECIFIC INQUIRY

inquiry
Size:
Conjugation:
Endotoxin:
Purity:
Engineering:
Product Overview

Description

Brain uptake of therapeutic antibodies is severely limited by their size. To achieve enhanced BBB crossing, Creative Biolabs developed a BBB shuttle antibody platform by utilizing the endogenous macromolecule transportation pathway, known as receptor-mediated transcytosis (RMT). The engineered antibody-based carrier is believed to significantly to increase the macromolecule brain entry to combat CNS diseases.
Notes: The BBB antibody is made-to order and available in a customized format. Please don't hesitate contact us for more details.

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Mouse

Applications

Block; Inhib; In Vitro; In Vivo

Relevant Diseases

Neuroinflammation
Product Properties

Storage

Store at -20°C. Do not aliquot the antibody.

Research Use Only

For research use only
Target

Target

FGFR3

Official Name

FGFR3

Full Name

Fibroblast Growth Factor Receptor 3

Alternative Names

Fibroblast Growth Factor Receptor 3; EC 2.7.10.1; FGFR-3; JTK4; Fibroblast Growth Factor Receptor 3 Variant 4; Achondroplasia; Thanatophoric Dwarfism; Hydroxyaryl-Protein Kinase; Tyrosine Kinase JTK4;
Product Pictures
Neut

Figure 2 shows that FGFR3 neutralizing Fabs recognize IgII or IgII and III in the extracellular domain of FGFR3.

ELISA

Figure 3 shows that MSPR029 specifically recognizes the IIIc isoform of FGFR3.

FuncS

Figure 4 shows the results of a proliferation assay of FDCP-FR3IIIb or FDCP-FR3IIIc cells incubated with increasing doses of the indicated Fabs.

FuncS

Figure 5 shows the binding of iodinated MSPRO29 to FGFR3.

FuncS

Figure 6 AF shows selective binding of radiolabeled MS-PR029 to growth plate histology.

FuncS

Figure 7 shows the proliferation assay of FDCP-FR3 (C10) and FDCP-FR3ach cells incubated with FGF9 and increasing doses of the indicated Fabs.

FuncS

Figure 8 shows the recovery of RCS cell growth by MS-PROS4 and MSPRO59.

FuncS

Figure 9 shows the growth rate of bone treated with MS-PRO59.

FuncS

Figure 10 shows the results of a proliferation assay in which iodinated MSPRO29 retained its activity against FGFR3.

Publications

Publications (0)

gift-card

Related Products
For Research Use Only. Not For Clinical Use.
Product
Hot Products
Fill out this form for a quote Inquiry Form Send Inquiry
webinar
Inquiry Basket
compare

Send inquiry